Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Apr 1, 2025
Date Accepted: Jun 14, 2025

The final, peer-reviewed published version of this preprint can be found here:

Encouraging General Practitioners to Refer Patients With Insomnia to a Digital Therapeutic (Sleepio): Feasibility Repeated-Measures Intervention Study

Alkhaldi O, McMillan BM, Ainsworth J

Encouraging General Practitioners to Refer Patients With Insomnia to a Digital Therapeutic (Sleepio): Feasibility Repeated-Measures Intervention Study

JMIR Form Res 2025;9:e75359

DOI: 10.2196/75359

PMID: 40854228

PMCID: 12377788

Encouraging General Practitioners to Refer Insomnia Patients to a Digital Therapeutic (Sleepio): A feasibility Study

  • Ohoud Alkhaldi; 
  • Brian McMillan McMillan; 
  • John Ainsworth

ABSTRACT

Background:

Sleepio, a digital therapeutic offering digital cognitive behavioural therapy for insomnia, has been recommended by the National Institute for Health and Care Excellence (NICE) in the United Kingdom as an alternative to offering sleep hygiene or sleeping pills. However, understanding of the referral behaviour of general practitioners (GPs) regarding Sleepio is lacking.

Objective:

The aim of this study was to investigate the feasibility of using an intervention targeting GPs in Scotland to increase referrals of insomnia patients to Sleepio.

Methods:

GPs working in primary care in Scotland were invited to join the study. During the intervention, GPs reviewed an orientation on using Sleepio and received a visual reminder midway through the intervention. The primary outcome was the number of Sleepio referrals every two weeks over two months. The secondary outcome was the change in the GPs’ reported confidence level that Sleepio will be successful in reducing patients’ insomnia symptoms, and confidence in recommending Sleepio to patients.

Results:

Of the 23 GPs who joined the study, 16 completed all stages. The total number of Sleepio referrals in two months was 96 for all 16 GPs. In the first two weeks of the intervention, the mean referral rate to Sleepio was 22.4% for all 16 GPs, but this rate increased to 45% by the end of week 8. A repeated measures analysis indicated there was no statistically significant difference in GPs referral rates across four data points. GPs reported confidence level in recommending Sleepio increased significantly (Z = -3.436, P < 0.01), from a mean of 5.44 (somewhat confident) to 8.13 (very confident).

Conclusions:

This study explored the feasibility and impact of an intervention aimed at supporting GPs’ to refer patients with insomnia to the digital therapeutic, Sleepio. Improvements were seen in GP-reported confidence levels at recommending Sleepio. A large-scale intervention and a longer study duration could provide useful information concerning how long the intervention effect on GPs’ behaviour towards Sleepio referrals might be sustained.


 Citation

Please cite as:

Alkhaldi O, McMillan BM, Ainsworth J

Encouraging General Practitioners to Refer Patients With Insomnia to a Digital Therapeutic (Sleepio): Feasibility Repeated-Measures Intervention Study

JMIR Form Res 2025;9:e75359

DOI: 10.2196/75359

PMID: 40854228

PMCID: 12377788

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.